Minnesota-based medical device major Medtronic, Inc.'s (MDT) latest cardiac resynchronization therapy-pacemaker (CRT-P) – Viva CRT-P – has duly received the U.S. Food and Drug Administration (:FDA) ...
Medtronic-Sponsored Study Aims to Support Worldwide Indication Expansion for CRT-P in a Significantly Underserved Heart Failure Patient Population MINNEAPOLIS – Medtronic, Inc. today announced the ...
The SJM™ Quadra CRT-P System, with the Quartet™ LV lead is associated with a 63 percent reduction in LV lead deactivation or replacement ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc.
The Quadra Allure MP ™ CRT-P now offers patients the flexibility to undergo full-body diagnostic MRI scans for other conditions ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a ...
MILAN, Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT-P, its new cardiac resynchronization therapy ...
Please provide your email address to receive an email when new articles are posted on . Among patients with nonischemic cardiomyopathy who require cardiac resynchronization therapy, a pacemaker may ...
Minneapolis-based medical device company Medtronic revealed that it has received the CE Mark of approval from European authorities to market its cardiac resynchronization therapy-pacemaker, Viva CRT-P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results